Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kremsner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
MMW Fortschritte Der Medizin|October 29, 2000
[New preventive antimalaria drug. 3 tables, 2 months of protection. Interview by Petra Eiden]P Kremsner
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 1, 1987
[Successful treatment of antimony-resistant cutaneous leishmaniasis]P Kremsner, I Lang, H Kollaritsch
The Journal of Infectious Diseases|November 1, 1993
Soluble tumor necrosis factor receptors in Plasmodium vivax malariaP Kern, W V Kern, P Kremsner
Wiener Medizinische Wochenschrift (1946)|May 15, 1989
[Infectious diarrhea diseases]W Graninger, P Kremsner, S Breyer, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1990
Restoration of defective cytokine activity within lepromatous leprosy lesionsB Volc-Platzer, P Kremsner, H Stemberger, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1988
Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in NigeriaH Kollaritsch, H Stemberger, H Mailer, et al.
The Journal of Infectious Diseases|October 1, 1992
Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malariaP Kern, C J Hemmer, H Gallati, et al.
Postgraduate Medical Journal|January 1, 1987
Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjectsF Ambrosch, W Frisch-Niggemeyer, P Kremsner, et al.
Lancet (London, England)|May 10, 1986
Boosting properties of recombinant DNA hepatitis B vaccineF Ambrosch, P Kremsner, G Wiedermann, et al.
Postgraduate Medical Journal|January 1, 1987
Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccineG Wiedermann, F Ambrosch, P Kremsner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
MMW Fortschritte Der Medizin|October 29, 2000
[New preventive antimalaria drug. 3 tables, 2 months of protection. Interview by Petra Eiden]P Kremsner
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 1, 1987
[Successful treatment of antimony-resistant cutaneous leishmaniasis]P Kremsner, I Lang, H Kollaritsch
The Journal of Infectious Diseases|November 1, 1993
Soluble tumor necrosis factor receptors in Plasmodium vivax malariaP Kern, W V Kern, P Kremsner
Wiener Medizinische Wochenschrift (1946)|May 15, 1989
[Infectious diarrhea diseases]W Graninger, P Kremsner, S Breyer, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1990
Restoration of defective cytokine activity within lepromatous leprosy lesionsB Volc-Platzer, P Kremsner, H Stemberger, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1988
Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in NigeriaH Kollaritsch, H Stemberger, H Mailer, et al.
The Journal of Infectious Diseases|October 1, 1992
Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malariaP Kern, C J Hemmer, H Gallati, et al.
Postgraduate Medical Journal|January 1, 1987
Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjectsF Ambrosch, W Frisch-Niggemeyer, P Kremsner, et al.
Lancet (London, England)|May 10, 1986
Boosting properties of recombinant DNA hepatitis B vaccineF Ambrosch, P Kremsner, G Wiedermann, et al.
Postgraduate Medical Journal|January 1, 1987
Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccineG Wiedermann, F Ambrosch, P Kremsner, et al.
Pageof 2